Markets:

Overview

News

Currencies

International

Treasuries

AbCellera Biologics Inc. - Common Shares (NQ:ABCL)

3.120 +0.180 (+6.12%)

Streaming Delayed Price Updated: 2:35 PM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about AbCellera Biologics Inc. - Common Shares

< Previous 1 2 3 4 5 6 7 Next >

Micro/Small Cap Companies Using AI In Drug Discovery Up 35% In November ↗

December 06, 2023

The AI method is up to 250 times more efficient than the traditional method of drug discovery. reducing timelines for drug discovery, increasing accuracy of efficacy and safety predictions.

Via Talk Markets

Topics Artificial Intelligence

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

November 03, 2023

Via Benzinga

AbCellera Biologics (ABCL) Q3 2023 Earnings Call Transcript ↗

November 03, 2023

ABCL earnings call for the period ending September 30, 2023.

Via The Motley Fool

Topics Earnings

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

November 02, 2023

Via Benzinga

Why AbCellera Biologics Is Still A Buy Despite Dropping Royalties: Analyst On Long-Term Prospects ↗

August 31, 2023

Benchmark analyst Robert Wasserman reiterated a Buy rating on AbCellera Biologics Inc. (NASDAQ: ABCL),

Via Benzinga

Earnings Preview: AbCellera Biologics ↗

August 02, 2023

Via Benzinga

Recap: AbCellera Biologics Q1 Earnings ↗

May 04, 2023

Via Benzinga

4 Analysts Have This to Say About AbCellera Biologics ↗

February 28, 2023

Via Benzinga

Preview: AbCellera Biologics's Earnings ↗

February 20, 2023

Via Benzinga

3 AI Stocks You’ll Regret Not Buying Soon ↗

August 08, 2023

AI will have a big impact on biotech, which could help with drug discovery and create opportunities for these top AI stocks to invest in.

Via InvestorPlace

Why ResMed Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

August 04, 2023

Gainers Missfresh Limited (NASDAQ: MF) jumped 168% to $1.38 after the company announced entry of share purchase agreements for financing and business acquisition.

Via Benzinga

The Latest Analyst Ratings for AbCellera Biologics ↗

January 06, 2023

Via Benzinga

Apple, Fortinet, Microchip Technology And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

August 04, 2023

U.S. stock futures traded higher this morning on Friday. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

AbCellera Biologics (ABCL) Q2 2023 Earnings Call Transcript ↗

August 04, 2023

ABCL earnings call for the period ending June 30, 2023.

Via The Motley Fool

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

August 03, 2023

Via Benzinga

Why Lucid Group Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

July 12, 2023

Gainers Healthcare Triangle, Inc. (NASDAQ: HCTI) shares climbed 171.2% to $8.84 as the company launched initiative to prevent ransomware attacks in the $35 billion healthcare data market.

Via Benzinga

InMode, Daktronics, Domino's Pizza And Other Big Stocks Moving Higher On Wednesday ↗

July 12, 2023

U.S. stocks traded higher, with the Dow Jones gaining around 250 points on Wednesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Looking for Biotech AI Stocks? 3 Names That Will Benefit From the AI Boom ↗

July 08, 2023

AI is changing the face of biotechnology and drug discovery. Don't miss out on the next big boom in biotech, here are 3 stocks to consider.

Via InvestorPlace

Why CohBar Shares Are Trading Lower By 161%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

May 23, 2023

Gainers

Via Benzinga

7 Growth Stocks That Could Double Your Money in 2023 ↗

May 14, 2023

For investors that really want to roll the dice, these are the enticing growth stocks that could double your money.

Via InvestorPlace

AbCellera Biologics (ABCL) Q1 2023 Earnings Call Transcript ↗

May 05, 2023

ABCL earnings call for the period ending March 31, 2023.

Via The Motley Fool

How AI Is Revolutionizing Tech, and Why You Should Invest in These Leading Companies ↗

April 28, 2023

Check out these compelling opportunities.

Via The Motley Fool

7 Stocks Under $10 That Analysts Love ↗

April 24, 2023

While these ideas might seem super cheap in a bad way, these stocks under $10 also rank among Wall Street analysts’ top picks.

Via InvestorPlace

1 Sector Received $6.1 Billion in AI Investments Last Year: 3 Top Stocks to Buy ↗

April 13, 2023

These companies are leading the way in using AI in healthcare.

Via The Motley Fool

7 Best Stocks Under $10 to Buy in April ↗

April 11, 2023

Although these stocks under $10 to buy may be cheap, their underlying businesses could yield significant upside.

Via InvestorPlace

7 Thrilling Biotech Stocks for Aggressive Investors to Buy ↗

April 05, 2023

Amid the noise of the global markets recently, these speculative biotech stocks to buy might trade with a mind of their own.

Via InvestorPlace

7 Stocks to Bet On if You Want to Be Richer Than Elon Musk ↗

March 22, 2023

If you can handle the heat of extreme speculation, you may want to throw some gambling funds at these stocks that can make you rich.

Via InvestorPlace

Benzinga's Top Ratings Upgrades, Downgrades For February 28, 2023 ↗

February 28, 2023

Via Benzinga

AbCellera Biologics (ABCL) Q4 2022 Earnings Call Transcript ↗

February 21, 2023

ABCL earnings call for the period ending December 31, 2022.

Via The Motley Fool

The 7 Most Undervalued Biotech Stocks to Buy in February 2023 ↗

February 02, 2023

Get your hands on the latest medical innovations at a compelling discount with the most undervalued biotech stocks to buy.

Via InvestorPlace

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

AbCellera Biologics Inc. - Common Shares (NQ:ABCL)

Headline News about AbCellera Biologics Inc. - Common Shares

Starting at $3.75/week.

Subscribe Today